EC
TEVA icon

Elequin Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Elequin Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.6K Buy
+1,228
New +$40.9K ﹤0.01% 334

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Elequin Capital's TEVA Position: Q2 2026 in Review

Elequin Capital opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 1,228 shares worth $41.6K. The stake represents ﹤0.01% of the portfolio and ranks #334 among its holdings.

676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Elequin Capital held 1,228 shares of Teva Pharmaceutical Industries Limited worth $41.6K as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new Elequin Capital position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #334 holding.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.